There is evidence that citicoline is the only neuroprotectant able to improve the functional
status of the patients after an acute ischemic stroke.
Citicoline is a neuroprotectant drug against cerebral ischemia, with positive results, both
in experimental and clinical trials, in the treatment of acute stroke and head injuries
Also, the safety profile of citicoline is good, and there are no associated problems when the
drug is used in this kind to patients
The aim of this study is to confirm the efficacy and safety of citicoline in patients with
moderate-to-severe acute ischemic stroke in Egypt, according to the characteristics of the
medical care in this country